Volatile organic compound detection of Buruli ulcer disease: Headspace analysis of Mycobacterium ulcerans and used gauzes of Buruli-compatible ulcers
- PMID: 39312571
- PMCID: PMC11449299
- DOI: 10.1371/journal.pntd.0012514
Volatile organic compound detection of Buruli ulcer disease: Headspace analysis of Mycobacterium ulcerans and used gauzes of Buruli-compatible ulcers
Abstract
Diagnosing Buruli ulcer (BU) is complicated by limited access to the sensitive IS2404 qPCR. Experienced clinicians report a distinct odour of Buruli ulcers. We explored the potential of headspace analysis by thermal desorption-gas chromatography-mass spectrometry to detect volatile organic compounds (VOCs) from Mycobacterium ulcerans both in vitro and clinically. This study was conducted in two phases: a discovery and validation phase. During the discovery phase, VOCs that enable identification of M. ulcerans cultures were determined. During the validation phase, these VOCs were evaluated in clinical samples for which we used gauzes from patients with skin ulcerations in the Democratic Republic of Congo. Seven M. ulcerans headspace samples were compared with four from sterile growth medium and laboratory environmental air. The univariate analysis resulted in the selection of 24 retained VOC fragments and a perfect differentiation between cultures and controls. Sixteen of 24 fragments were identified, resulting in eleven unique compounds, mainly alkanes. Methylcyclohexane was the best performing compound. Based on these 24 fragments, headspace samples originating from gauzes of 50 open skin lesions (12 qPCR positive and 38 negative) were analysed and an AUC of 0.740 (95%-CI 0.583-0.897) was obtained. As this is an experimental study, future research has to confirm whether the identified compounds can serve as novel biomarkers.
Copyright: © 2024 Chudy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease).PLoS Negl Trop Dis. 2010 Jul 6;4(7):e736. doi: 10.1371/journal.pntd.0000736. PLoS Negl Trop Dis. 2010. PMID: 20625556 Free PMC article.
-
Detection of Mycobacterium ulcerans with IS2404 loop-mediated isothermal amplification and a fluorescent reporter probe.Appl Environ Microbiol. 2025 May 21;91(5):e0027025. doi: 10.1128/aem.00270-25. Epub 2025 Apr 16. Appl Environ Microbiol. 2025. PMID: 40237451 Free PMC article.
-
Mycobacterium ulcerans Population Genomics To Inform on the Spread of Buruli Ulcer across Central Africa.mSphere. 2019 Feb 6;4(1):e00472-18. doi: 10.1128/mSphere.00472-18. mSphere. 2019. PMID: 30728280 Free PMC article.
-
The Buruli Ulcer.Int J Low Extrem Wounds. 2015 Sep;14(3):217-23. doi: 10.1177/1534734615599653. Epub 2015 Aug 18. Int J Low Extrem Wounds. 2015. PMID: 26286931 Review.
-
What about Current Diversity of Mycolactone-Producing Mycobacteria? Implication for the Diagnosis and Treatment of Buruli Ulcer.Int J Mol Sci. 2023 Sep 6;24(18):13727. doi: 10.3390/ijms241813727. Int J Mol Sci. 2023. PMID: 37762030 Free PMC article. Review.
References
-
- Buruli Ulcer (Mycobacterium Ulcerans infection) World Health Organisation; [updated 2022. http://www.who.int/mediacentre/factsheets/fs199/en/.
-
- Kanga JM, Kacou ED. [Epidemiologicl aspects of Buruli ulcer in Côte d’Ivoire: results of a national survey]. Bull Soc Pathol Exot. 2001;94(1):46–51. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials